Congenital and acquired urologic abnormalities including neurogenic bladder secondary to spinia bifida or spinal cord injury, posterior urethral valves, and benign prostatic hyperplasia frequently result in urinary tract obstruction which ultimately leads to diminished bladder capacity and poor compliance. Urinary incontinence, recurrent urinary tract infections, and renal failure are debilitating consequences of obstructive bladder diseases. Enterocystoplasty is utilized as the primary approach to increase bladder capacity and decrease high intravesical pressures in order to preserve renal function in patients afflicted with pathological bladder obstruction. However, the long term efficacy of this technique is hampered by frequent and severe complications which negatively impact patient quality of life. Silk fibroin (SF)-based implants provide an exceptional combination of physical characteristics that are well suited to support bladder function. Therefore, these scaffolds may overcome the deleterious side-effects associated with enterocystoplasty and serve as an off the shelf graft for bladder reconstruction. Given the role of M2 macrophage activation in orchestrating regenerative responses, we anticipate that SF scaffolds which can promote an M2 phenotype during defect consolidation will be beneficial in improving pathological bladder performance. In this proposal, we will test the overall hypothesis that: bladder augmentation with SF biomaterials capable of delivering pro-M2 macrophage activation factors (IL-4, IL-13) will serve as a superior approach for improving pathological bladder function in comparison to enterocystoplasty.
The specific aims of the application are:
Specific Aim 1 : Determine the impact of SF scaffold properties on constructive remodeling and organ function following augmentation cystoplasty in a porcine model of partial bladder outlet obstruction.
Specific Aim 2 : Evaluate the utility of SF-based, IL-4/IL-13-delivery systems to induce M2 macrophage activation, enhance constructive remodeling, and improve obstructed bladder function.

Public Health Relevance

The results of this proposal are anticipated to produce new tissue repair strategies that will overcome current limitations in enterocystoplasty and enhance our understanding of the role of the innate host immune response in dictating constructive remodeling within the urinary tract. We seek to expand our knowledge of the nature, extent, and significance of biomaterial configurations necessary to optimize functional tissue replacement in setting of obstructive bladder diseases. We anticipate the results of this study will provide new information that is wider in scope than our specific goals and which may be applicable for repair of other urogenital tissues and visceral hollow organs in general.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21EB020860-01
Application #
8952723
Study Section
Special Emphasis Panel (ZRG1-DKUS-G (90))
Program Officer
Hunziker, Rosemarie
Project Start
2015-07-06
Project End
2017-06-30
Budget Start
2015-07-06
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
$220,938
Indirect Cost
$95,938
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Sack, Bryan S; Mauney, Joshua R; Estrada Jr, Carlos R (2016) Silk Fibroin Scaffolds for Urologic Tissue Engineering. Curr Urol Rep 17:16